All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| NBRV / Nabriva Therapeutics Plc
|
|
|
|
|
|
|
|
| GILD / Gilead Sciences, Inc. Call
|
|
|
|
|
|
|
|
| NVLN / NOVELION THERAPEUTICS INC.
|
|
|
|
|
|
|
|
| / Array BioPharma, Inc.
|
|
|
|
|
|
|
|
| US33830X1046 / Five Prime Therapeutics Inc
|
|
|
|
|
|
|
|
| CBIO / Crescent Biopharma, Inc.
|
|
|
|
|
|
|
|
| 91911K102 / Bausch Health Companies Call
|
|
|
|
|
|
|
|
| FWP / Forward Pharma A/S - ADR
|
|
|
|
|
|
|
|
| RGLS / Regulus Therapeutics Inc. Call
|
|
|
|
|
|
|
|
| MCRB / Seres Therapeutics, Inc.
|
|
|
|
|
|
|
|
| 87611RAA6 / Targacept Inc Bond
|
|
|
|
|
|
|
|
| 04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020
|
|
|
|
|
|
|
|
| EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
| / Array BioPharma, Inc. Call
|
|
|
|
|
|
|
|
| FGEN / FibroGen, Inc.
|
|
|
|
|
|
|
|
| 17K / Self Storage Group ASA
|
|
|
|
|
|
|
|
| COLL / Collegium Pharmaceutical, Inc.
|
|
|
|
|
|
|
|
| GNVC / GenVec, Inc.
|
|
|
|
|
|
|
|
| EPZM / Epizyme Inc Call
|
|
|
|
|
|
|
|
| 09074D103 / Biotie Therapies Corp.
|
|
|
|
|
|
|
|
| OREX / Orexigen Therapeutics, Inc.
|
|
|
|
|
|
|
|
| LIFE / aTyr Pharma, Inc.
|
|
|
|
|
|
|
|
| CALA / Calithera Biosciences, Inc.
|
|
|
|
|
|
|
|
| AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| TPST / Tempest Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
| CASC / Cascadian Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ASMB / Assembly Biosciences, Inc.
|
|
|
|
|
|
|
|
| FLKS / Flex Pharma, Inc.
|
|
|
|
|
|
|
|
| EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| KITE / Kite Pharma, Inc.
|
|
|
|
|
|
|
|
| TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ATRA / Atara Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
